The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer's disease.

Publisher: BioMed Central Country of Publication: England NLM ID: 101591861 Publication Model: Electronic Cited Medium: Print ISSN: 2047-9158 (Print) Linking ISSN: 20479158 NLM ISO Abbreviation: Transl Neurodegener Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2012-

Alzheimer Disease*/metabolism ; tau Proteins*/metabolism ; Amyloid beta-Peptides*/metabolism ; Biomarkers* ; Neuroglia*/metabolism ; Neuroglia*/pathology; Humans ; Synapses/metabolism ; Synapses/pathology ; Nerve Degeneration/metabolism ; Nerve Degeneration/pathology

Mol Neurobiol. 2019 Aug;56(8):5568-5585. (PMID: 30652266)
Neurology. 2021 Nov 23;97(21):e2065-e2078. (PMID: 34556565)
J Nucl Med. 2022 Jun;63(Suppl 1):60S-67S. (PMID: 35649655)
Sci Transl Med. 2022 Jun;14(647):eabi8593. (PMID: 35648810)
J Alzheimers Dis. 2017;57(4):1105-1121. (PMID: 28059794)
Sci Transl Med. 2016 Jul 20;8(348):348ra96. (PMID: 27440727)
Brain. 2021 Feb 12;144(1):310-324. (PMID: 33279949)
Nat Rev Neurol. 2023 Jan;19(1):19-38. (PMID: 36513730)
Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):26239-26246. (PMID: 31871145)
Biomark Insights. 2020 Aug 21;15:1177271920950319. (PMID: 32913390)

MOP-11-51-31 Canada CAPMC CIHR

0 (tau Proteins)
0 (Amyloid beta-Peptides)
0 (Biomarkers)

Date Created: 20240527 Date Completed: 20240528 Latest Revision: 20240604

20240604

PMC11131272

10.1186/s40035-024-00420-1

38802928